A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

10.6K views

⸱

DOI:

10.3791/53904

⸱

May 20th, 2016

 ,  ,  ,  ,  ,  , 

In This Article

Summary

We describe a method for the detection of tumor nodule development in the lungs of an adenocarcinoma mouse model using micro-computed tomography and its use for monitoring changes in nodule size over time and in response to treatment. The accuracy of the assessment was confirmed with end-point histological quantification.

Abstract

Lung cancer is the most lethal cancer in the world. Intensive research is ongoing worldwide to identify new therapies for lung cancer. Several mouse models of lung cancer are being used to study the mechanism of cancer development and to experiment with various therapeutic strategies. However, the absence of a real-time technique to identify the development of tumor nodules in mice lungs and to monitor the changes in their size in response to various experimental and therapeutic interventions hampers the ability to obtain an accurate description of the course of the disease and its timely response to treatments. In this study, a method using a micro-computed tomography (CT) scanner for the detection of the development of lung tumors in a mouse model of lung adenocarcinoma is described. Next, we show that monthly follow-up with micro-CT can identify dynamic changes in the lung tumor, such as the appearance of additional nodules, increase in the size of previously detected nodules, and decrease in the size or complete resolution of nodules in response to treatment. Finally, the accuracy of this real-time assessment method was confirmed with end-point histological quantification. This technique paves the way for planning and conducting more complex experiments on lung cancer animal models, and it enables us to better understand the mechanisms of carcinogenesis and the effects of different treatment modalities while saving time and resources.

Introduction

Lung cancer is the leading cause of cancer death around the world1. Research into the prevention, early detection, and treatment of lung cancer is ongoing in many research centers throughout the world2,3. Several animal models for lung cancer have been developed, and they have proven useful in studying the mechanisms of lung carcinogenesis and cell of origin, in determining the presence of cancer stem cells, and in examining various novel therapeutic strategies4. Earlier models relied on carcinogen-induced tumor initiation in sensitive strains of mice5. The development of knockout and transgenic mouse models in which lung ca....

Access restricted. Please log in or start a trial to view this content.

Protocol

Animal experiments were approved by the Institutional Animal Care and Use Committee of Keio University.

Note: In this study, we used the Sftpc-rtTA and Tre-Fgf9-ires-eGfp DT mice in which lung adenocarcinoma rapidly develops after induction by feeding chow containing doxycycline6,7. However, all assessment procedures can be applied to other lung cancer mouse models.

1. Experiment Outline:

  1. Identify the status of the lungs at the baseline:
    1. Before tumor induction, when the DT mice are 8 - 12 weeks old, perform the first micro-CT scan (see sections 2 and 3 below). ....

Access restricted. Please log in or start a trial to view this content.

Results

Identification of mice with lung abnormalities was performed at baseline. Before tumor induction, when the DT mice were 8 - 12 weeks of age, the lungs of all mice were scanned with micro-CT. Surprisingly, approximately 50% of mice showed abnormalities that forced us to deem them unsuitable for inclusion in the subsequent study. These abnormalities were nodule-like shadows, large single or multiple small emphysematous bullae and/or lobar atelectasis (Figure 1A, C, D-E, G-H.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The micro-CT-based method described here for the real-time identification of lung abnormalities and monitoring of the development of tumor nodules and the response to treatment in lung cancer animal models will enable scientists who are conducting lung cancer-related experiments to plan more accurate and efficient experiments while saving time and resources. We have previously used MRI for the same purpose6. The clarity of the scan and threshold for the detection of lung nodules with MRI were inferior to those.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that they have no competing financial interests.

Acknowledgements

This work was supported by a Grant-in-Aid from JSPS KAKENHI for A.E.H. (Grant Number 25461196) and T.B. (Grant Numbers 23390218 and 15H04833) and National Institutes of Health grant HL111190 (D.M.O.). The authors would like to acknowledge Miyuki Yamamoto for her efforts in helping with animal genotyping and the preparation of histological sections. We are grateful to the Collaborative Research Resources, School of Medicine, Keio University for technical support and reagents.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
micro-X-ray–computed tomographyRigakuR_mCT2
NanoZoomer RS Digital Pathology SystemHamamatsu RS C10730
NDP.view2 Viewing softwareHamamatsu U12388-01http://www.hamamatsu.com/jp/en/U12388-01.html
Isoflurane Vaporizer - Funnel-FillVETEQUIP911103
Induction chamber, 2 L  W9.5 × D23 × H9.5VETEQUIP941444
IsofluraneMylanES2303-01
AZD 4547LC LabratoriesA-1088
PentobarbitalKyoritsuSOM02-YA1312
G24 cannula TerumoSP-FS2419
ParaformaldehydeWako163-20145
MicrotomeLeicaRM2265
DoxycyclineSLC Japan/PMI Nutrition International5TP7
ImageJ software National Institute of healthhttp://imagej.nih.gov/ij/
Puralube vet ointment (Occular lubricant)DechraNDC 17033-211-38

References

  1. Ferlay, J., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 136, 359-386 (2015).
  2. Mak, I. W., Evaniew, N., Ghert, M. Lost in translation: animal models and ....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Micro CTTreatment ResponseImage AnalysisAnesthesia ProtocolHistological ValidationFGFR InhibitorDoxycycline Induction